Dental Implantology Software Market Growth Analysis and Forecast to 2032

According to Future Market Insights (FMI), the global Dental Implantology Software market revenue will grow due to the desire for a faster and easier implant process. This programme reduces the amount of time the patient needs to spend in surgery and allows the dental team to analyse all operations prior to surgery, making the process less expensive.

The dental team can make better selections for the patient's rehabilitation and reduce post-surgery issues with earlier analysis. By employing 3D scans and dental planning software, practitioners may make more precise selections with Dental Implantology Software. As a result, worldwide demand for Dental Implantology Software is predicted to rise dramatically between 2022 and 2032.

The global Dental Implantology Software market is anticipated to be valued US$ 214.2 million by the end of 2022, growing at a CAGR of 2.7% between 2022 and 2032, to reach US$ 278.2 million by 2032. In terms of product type, the design software sector led the market in 2021, accounting for around 75.0% of the total.

dentistry implants are used in cosmetic and aesthetic dentistry procedures to repair the gap caused by a lost tooth, which raises the risk of various dental problems. As a result of growing awareness of oral health and rising desire for cosmetic dentistry around the world, demand for Dental Implantology Software is predicted to rise.

Key Players

  • Dentsply Sirona
  • Dental Wings Inc.
  • Blue Sky Bio
  • PLANMECA OY
  • exocad GmbH
  • Institut Straumann AG
  • ImplaStation
  • Materialise
  • Reconstruction 3D
  • DTX Studio suite (Envista)
  • GuideMia Technologies Inc
  • Zuub Inc

Browse More Details@ https://www.futuremarketinsights.com/reports/dental-implantology-software-market

Key Market Segments Covered in Dental Implantology Software Industry Research

By Product:

  • Planning Software
  • Design Software

By End User:

  • Hospitals
  • Dental Clinics
  • Ambulatory Surgical Centers
  • Academic & Research Institutes

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more